Nasdaq delists Insys after bankruptcy filing; China's Zai Lab licenses solid tumor drug from Deciphera
→ On the heels of a bankruptcy filing, Insys announced that it’s getting delisted from the Nasdaq. Trading of the stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
